Eli Lilly and Company

Historical 13F Holders

Symbol
LLY
CUSIP
532457108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 532457108 since 12/18/2024, largest first.

Filer % of Class Filed
Lilly Endowment Inc 13G/A 9.6% 7/23/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 6.5% 5/1/2026
Event 3/31/2026
PNC Financial Services Group, Inc. 13G/A 5.4% 2/7/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 698 8.43 M $9.68 B
2026 Q2 4,887 2.25 B $946 B
2026 Q1 4,612 778 M $713 B
2025 Q4 4,683 795 M $847 B
2025 Q3 4,161 777 M $592 B
2025 Q2 4,157 789 M $614 B
2025 Q1 4,145 838 M $691 B
2024 Q4 4,114 783 M $604 B
2024 Q3 3,863 811 M $705 B
2024 Q2 3,776 815 M $737 B
2024 Q1 3,666 828 M $643 B
2023 Q4 3,449 822 M $479 B
2023 Q3 3,131 788 M $424 B
2023 Q2 2,961 786 M $368 B
2023 Q1 2,748 843 M $271 B
2022 Q4 2,799 828 M $304 B
2022 Q3 2,621 800 M $260 B
2022 Q2 2,565 789 M $256 B
2022 Q1 2,451 792 M $227 B
2021 Q4 2,418 793 M $219 B
2021 Q3 2,169 793 M $183 B
2021 Q2 2,132 795 M $182 B
2021 Q1 2,045 794 M $148 B
2020 Q4 1,990 796 M $135 B
2020 Q3 1,871 737 M $109 B
2020 Q2 1,869 745 M $122 B
2020 Q1 1,786 754 M $105 B
2019 Q4 1,776 759 M $99.8 B
2019 Q3 1,619 747 M $83.5 B
2019 Q2 1,615 759 M $84.1 B
2019 Q1 1,715 783 M $102 B
2018 Q4 1,664 841 M $97.3 B
2018 Q3 1,537 848 M $90.9 B
2018 Q2 1,461 848 M $72.2 B
2018 Q1 1,423 846 M $65.4 B
2017 Q4 1,469 862 M $72.6 B
2017 Q3 1,312 851 M $72.7 B
2017 Q2 1,331 843 M $69.4 B
2017 Q1 1,353 847 M $71.2 B
2016 Q4 1,325 837 M $61.5 B
2016 Q3 1,268 836 M $67.1 B
2016 Q2 1,256 839 M $66.1 B
2016 Q1 1,223 849 M $59.9 B
2015 Q4 1,299 857 M $72.2 B
2015 Q3 1,207 852 M $71.5 B
2015 Q2 1,207 847 M $70.7 B
2015 Q1 1,167 843 M $61.3 B
2014 Q4 1,200 851 M $59.0 B
2014 Q3 1,113 840 M $54.6 B
2014 Q2 1,100 859 M $54.6 B
2014 Q1 1,098 836 M $49.6 B